Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Becky McCall

News

Should we rename obesity?

Author:
Becky McCall
Publish date: August 7, 2023

“The word is so stigmatized, with so much misunderstanding and misperception, some might say the only solution is to change the name.”

  • Read More

News

Naltrexone is safe and beneficial in AUD with cirrhosis

Author:
Becky McCall
Publish date: July 14, 2023

VIENNA – Naltrexone can be safely administered to patients with alcohol use...

  • Read More

News

SAFE algorithm detects liver disease in general population

Author:
Becky McCall
Publish date: June 26, 2023

Scoring system was developed and validated to detect clinically significant (greater than stage 2) fibrosis in patients with NAFLD in primary care...

  • Read More

News

‘Exciting time for NASH’ with resmetirom phase 3 results

Author:
Becky McCall
Publish date: June 23, 2023

Two doses of resmetirom met the primary endpoints of NASH resolution and no worsening of fibrosis on liver biopsy.

  • Read More

News

New EULAR lupus recommendations advise using biologics, tapering steroids

Author:
Becky McCall
Publish date: June 14, 2023

The 2023 recommendations cover new treatment strategies with more ambitious goals, new data on adverse effects of chronic glucocorticoid use, and...

  • Read More

News

Investigational uricase-based gout drug meets primary endpoints in phase 3 trials

Author:
Becky McCall
Publish date: June 6, 2023

Two phase 3 trials of the once-monthly SEL-212 in refractory gout achieved and maintained serum uric acid < 6 mg/dL for ≥ 80% of the final...

  • Read More

News

EULAR systemic sclerosis recommendations now include immunosuppressants

Author:
Becky McCall
Publish date: June 5, 2023

The update to 2017 recommendations include targeted synthetic and biologic DMARDs for the first time.

  • Read More

News

URAT1 inhibitor shows ‘substantial’ uric acid reduction in phase 2 gout trial

Author:
Becky McCall
Publish date: June 5, 2023

The investigational drug, AR882, reduced serum uric acid to levels seen in people without hyperuricemia and gout.

  • Read More

News

Encouraging telitacicept results reported in phase 3 for lupus, phase 2 for Sjögren’s

Author:
Becky McCall
Publish date: June 2, 2023

Results of a phase 3 trial in Chinese patients with systemic lupus erythematosus showed a significantly greater response rate with telitacicept,...

  • Read More

News

ILD risk elevated in RA, PsA after starting biologic or targeted synthetic DMARDs

Author:
Becky McCall
Publish date: June 1, 2023

The risk for interstitial lung disease in patients with PsA during the first 5 years after starting a biologic or targeted synthetic DMARD was...

  • Read More

News

Tweaking food delivery apps can lower calories purchased

Author:
Becky McCall
Publish date: May 24, 2023

“These studies provide encouraging proof-of-concept evidence that small tweaks in delivery apps could help many people to identify and select...

  • Read More

News

‘Staggering’ weight loss and benefits in body composition with tirzepatide

Author:
Becky McCall
Publish date: May 19, 2023

“Something we have sought for decades, we have finally been able to achieve.”

  • Read More

News

Ear acupuncture with diet aids weight loss

Author:
Becky McCall
Publish date: May 19, 2023

Acupuncture beads, used in Japan to augment weight loss for more than 30 years, are thought to stimulate nerves and organs that regulate appetite...

  • Read More

News

Half of teens drop below obesity cutoff with semaglutide

Author:
Becky McCall
Publish date: May 18, 2023

The semaglutide findings are “historically unprecedented with treatments other than bariatric surgery.”

  • Read More

News

Obesity drug with swallowable balloon boosts weight loss

Author:
Becky McCall
Publish date: May 18, 2023

“In Europe, use of the swallowable gastric balloon is common, the results are good, and it is a safe tool.”

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close